Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-16

Clinical Trial Update: An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing potential interactions between gemigliptin and metformin in healthy Mexican volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemigliptin (gemigliptin)
  • metformin (metformin)

Snippet

Sponsor: Stendhal Americas, S.A. | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED